Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has expanded its laboratory operations in Stockholm, Sweden. The move follows Circio’s recent generation of promising circVec circular RNA expression data in the fields of gene and cell therapy. This expansion will enable Circio to further accelerate pre-clinical development towards its first therapeutic candidates. Circio’s recently published series of data demonstrate...